ALT5 Sigma Corp
NASDAQ:ALTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ALT5 Sigma Corp
Total Receivables
ALT5 Sigma Corp
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ALT5 Sigma Corp
NASDAQ:ALTS
|
Total Receivables
$28.8m
|
CAGR 3-Years
61%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Receivables
$17.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Receivables
$14.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Receivables
$15.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Receivables
$12.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Receivables
$20.2B
|
CAGR 3-Years
33%
|
CAGR 5-Years
24%
|
CAGR 10-Years
17%
|
|
ALT5 Sigma Corp
Glance View
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2006-02-22. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.
See Also
What is ALT5 Sigma Corp's Total Receivables?
Total Receivables
28.8m
USD
Based on the financial report for Sep 27, 2025, ALT5 Sigma Corp's Total Receivables amounts to 28.8m USD.
What is ALT5 Sigma Corp's Total Receivables growth rate?
Total Receivables CAGR 10Y
8%
Over the last year, the Total Receivables growth was 32%. The average annual Total Receivables growth rates for ALT5 Sigma Corp have been 61% over the past three years , 40% over the past five years , and 8% over the past ten years .
